Literature DB >> 9854102

Molecular evidence for transmission of human T-lymphotropic virus type II infection by a human bite.

W V Bolton1, A R Davis, Y C Ge, D E Dwyer, K G Kenrick, A L Cunningham, N K Saksena.   

Abstract

Investigation of a human T-lymphotropic virus type II (HTLV-II) infection in a female Australian blood donor identified a human bite as the likely mode of transmission, confirmed by nucleotide sequencing of the proviral tax/rex from both donor and contact. We believe this to be the first report of the transmission of an HTLV by a human bite.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854102      PMCID: PMC84221     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Mutational analysis of human T-cell leukemia virus type 2 Tax.

Authors:  T M Ross; A C Minella; Z Y Fang; S M Pettiford; P L Green
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.

Authors:  A M Vandamme; M Salemi; M Van Brussel; H F Liu; K Van Laethem; M Van Ranst; L Michels; J Desmyter; P Goubau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO.

Authors:  E L Murphy; R Mahieux; G de Thé; F Tekaia; D Ameti; J Horton; A Gessain
Journal:  Virology       Date:  1998-03-15       Impact factor: 3.616

4.  Transmission of HIV-1 by human bite.

Authors:  L Vidmar; M Poljak; J Tomazic; K Seme; I Klavs
Journal:  Lancet       Date:  1996-06-22       Impact factor: 79.321

5.  Partial nucleotide sequence analysis of the first case of human T lymphotropic virus type II from Australia.

Authors:  W V Bolton; K G Kenrick; D E Dwyer; A L Cunningham; B R Wylie; N K Saksena
Journal:  AIDS Res Hum Retroviruses       Date:  1995-06       Impact factor: 2.205

6.  Detection of HTLV type I provirus by in situ polymerase chain reaction in mouthwash mononuclear cells of HAM/TSP patients and HTLV type I carriers.

Authors:  A Achiron; I Higuchi; N Takenouchi; E Matsuoka; K Hashimoto; S Izumo; B Shohat; M Osame
Journal:  AIDS Res Hum Retroviruses       Date:  1997-08-10       Impact factor: 2.205

7.  Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2.

Authors:  N Eiraku; P Novoa; M da Costa Ferreira; C Monken; R Ishak; O da Costa Ferreira; S W Zhu; R Lorenco; M Ishak; V Azvedo; J Guerreiro; M P de Oliveira; P Loureiro; N Hammerschlak; S Ijichi; W M Hall
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.

Authors:  V S Kalyanaraman; M G Sarngadharan; M Robert-Guroff; I Miyoshi; D Golde; R C Gallo
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

9.  The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports an African origin for the human T-lymphotropic/simian T-lymphotropic group of viruses.

Authors:  A M Vandamme; H F Liu; M Van Brussel; W De Meurichy; J Desmyter; P Goubau
Journal:  J Gen Virol       Date:  1996-05       Impact factor: 3.891

Review 10.  Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection.

Authors:  W W Hall; R Ishak; S W Zhu; P Novoa; N Eiraku; H Takahashi; M da C Ferreira; V Azevedo; M O Ishak; O da C Ferreira; C Monken; T Kurata
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996
View more
  1 in total

1.  Management of human bites of the face in Enugu, Nigeria.

Authors:  Peter B Olaitan; Antonia O Uduezue; Godwin C Ugwueze; Iheuko S Ogbonnaya; Uche J Achebe
Journal:  Afr Health Sci       Date:  2007-03       Impact factor: 0.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.